Innovations in transdermal delivery: Exploring nicotine patches, microneedles and glucose monitoring technologies

Vaishnavi G. Karule *, Jitendra A. Kubde, Pooja R. Hatwar, Ravindra L. Bakal and Khushi S. Kathole

Shri Swami Samarth Institute of Pharmacy, At Parsodi, Dhamangaon Rly, Dist -Amravati (444709) Maharashtra, India.
 

 

Review Article
GSC Biological and Pharmaceutical Sciences, 2024, 29(02), 341–355.
Article DOI: 10.30574/gscbps.2024.29.2.0436
Publication history: 
Received on 10 October 2024; revised on 23 November 2024; accepted on 26 November 2024
 
Abstract: 
Transdermal devices for delivering drugs have been invented in response to obstacles caused by oral administration of medications. An adhesive patch comprising medication that is applied topically for transferring a preset proportion of treatment through the skin and into the bloodstream is called a transdermal patch. The method of manufacturing for various transdermal application types, including matrix patches, is described in this review article. Addiction to cigarettes affects millions different people throughout. One example of a nicotine replacement treatment that is currently widely accessible and utilized is transdermal nicotine patches. Nicotine substitution therapy is an assortment of products that provide nicotine and are authorized for use as a smoking cessation aid for the treatment of withdrawal. An increasing number of participants have been impacted by the global rise in diabetes in the past few years are experiencing discomfort and infections because of the intrusive design of most commercial glucose meters. Non-invasive blood glucose monitoring technology is now a hot issue for research worldwide and a novel approach that has the potential to help a lot of patients.
 
Keywords: 
Transdermal Patches; Nicotine patches; Nicotine replacement therapy; Transdermal Glucose Monitoring
 
Full text article in PDF: 
Share this